Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 Biomarker disease BEFREE Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. 30214007 2018
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 AlteredExpression disease BEFREE To investigate whether downregulation of APE1/Ref-1 expression by ribonucleic acid interference would increase the sensitivity of chromic-P32 phosphate to pancreatic cancer cells. 23268706 2013
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 AlteredExpression disease BEFREE Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo. 20018303 2011
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 Biomarker disease BEFREE Endogenous cell cycle inhibitors increase when APE1/ Ref-1 is reduced, demonstrating its importance to proliferation and growth of pancreatic cancer. 20919954 2010
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 Biomarker disease BEFREE Our data suggest that TFPI-2 plays a significant role in the invasion and metastasis of pancreatic carcinoma cell in vitro and in vivo and is determined to be an important prognostic factor for pancreatic carcinoma patients. 19763915 2010
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 AlteredExpression disease BEFREE Our results show that Ape1/Ref-1 is a novel physiological regulator of GDNF responsiveness, and they also suggest that Ape1/Ref-1-induced GFRalpha1 expression may play important roles in pancreatic cancer progression and neuronal cell survival. 19188437 2009
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 Biomarker disease BEFREE QMSP could accurately distinguish patients with pancreatic cancer and other periampullary cancers from those with benign periampullary disease; 73.2% of patients with pancreatic ductal adenocarcinoma had at least 1 gene positive for methylation by QMSP (defined as > or =1% TFPI-2 DNA and > or =3% methylated NPTX2 and Cyclin D2 DNA) in their brush samples, compared with 80% of patients with a biliary tract cancer and only 13.6% of patients with a benign stricture (P < .001). 18995218 2008
CUI: C0235974
Disease: Pancreatic carcinoma
Pancreatic carcinoma
0.080 PosttranslationalModification disease BEFREE The incidence of quantitative TFPI-2 hypermethylation in the PPJ with PCa was significantly higher than that with IPMN (P < 0.001) or CP (P < 0.001). 16965396 2006